{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:14:10Z","timestamp":1793985250883,"version":"4.8.0"},"reference-count":39,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2008,3,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To update eligibility and outcome measures in trials that evaluate systemic treatment for patients with progressive prostate cancer and castrate levels of testosterone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A committee of investigators experienced in conducting trials for prostate cancer defined new consensus criteria by reviewing previous criteria, Response Evaluation Criteria in Solid Tumors (RECIST), and emerging trial data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The Prostate Cancer Clinical Trials Working Group (PCWG2) recommends a two-objective paradigm: (1) controlling, relieving, or eliminating disease manifestations that are present when treatment is initiated and (2) preventing or delaying disease manifestations expected to occur. Prostate cancers progressing despite castrate levels of testosterone are considered castration resistant and not hormone refractory. Eligibility is defined using standard disease assessments to authenticate disease progression, prior treatment, distinct clinical subtypes, and predictive models. Outcomes are reported independently for prostate-specific antigen (PSA), imaging, and clinical measures, avoiding grouped categorizations such as complete or partial response. In most trials, early changes in PSA and\/or pain are not acted on without other evidence of disease progression, and treatment should be continued for at least 12 weeks to ensure adequate drug exposure. Bone scans are reported as \u201cnew lesions\u201d or \u201cno new lesions,\u201d changes in soft-tissue disease assessed by RECIST, and pain using validated scales. Defining eligibility for prevent\/delay end points requires attention to estimated event frequency and\/or random assignment to a control group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PCWG2 recommends increasing emphasis on time-to-event end points (ie, failure to progress) as decision aids in proceeding from phase II to phase III trials. Recommendations will evolve as data are generated on the utility of intermediate end points to predict clinical benefit.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1200\/jco.2007.12.4487","type":"journal-article","created":{"date-parts":[[2008,2,28]],"date-time":"2008-02-28T18:43:07Z","timestamp":1204224187000},"page":"1148-1159","source":"Crossref","is-referenced-by-count":1958,"title":["Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group"],"prefix":"10.1200","volume":"26","author":[{"given":"Howard I.","family":"Scher","sequence":"first","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Halabi","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Tannock","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Morris","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora N.","family":"Sternberg","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Carducci","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario A.","family":"Eisenberger","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestia","family":"Higano","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn J.","family":"Bubley","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dreicer","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Petrylak","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Kantoff","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Basch","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Kevin","family":"Kelly","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Figg","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Small","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz M.","family":"Beer","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Wilding","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Martin","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha","family":"Hussain","sequence":"additional","affiliation":[{"name":"From the Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY; Duke University Medical Center, Durham, NC; Princess Margaret Hospital, Toronto, Ontario, Canada; Sam Camillo Forlanini Hospital, Rome, Italy; Beth Israel Deaconess Medical Center; Dana-Farber Cancer Center, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore; National Cancer Institute, Bethesda, MD; University of Washington, Seattle, WA; Cleveland Clinic,..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"233","reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.11.3461"},{"key":"R2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/92.3.205"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0109"},{"key":"R4","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(99)00471-9"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1002\/j.1939-4640.2001.tb03433.x"},{"key":"R6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040720"},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041318"},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.4769"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.09.028"},{"key":"R11","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000141845.99899.12"},{"key":"R11A","unstructured":"Arlen PM, Bianco F, Dahut WL, et al: Prostate Specific Antigen Working Group's guidelines on PSA doubling time. J Urol , in press"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.00525"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-1146-03"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-0525"},{"key":"R14A","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3332"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63112-4"},{"key":"R16","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4000"},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(96)80011-2"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601232"},{"key":"R19","doi-asserted-by":"publisher","DOI":"10.1159\/000019546"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199810083391504"},{"key":"R21","doi-asserted-by":"publisher","DOI":"10.3816\/CGC.2005.n.015"},{"key":"R22","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.11.021"},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.06.100"},{"key":"R23A","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1036"},{"key":"R24","doi-asserted-by":"publisher","DOI":"10.1097\/01.cad.0000231468.69535.97"},{"key":"R25","unstructured":"Nelius T, Klatte T, de Riese W, et al: Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy. Int Urol Nephrol [epub ahead of print on June 30, 2007]"},{"key":"R26","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.04.176"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0664"},{"key":"R28","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.12.794"},{"key":"R29","doi-asserted-by":"crossref","unstructured":"Dixon SC, Knopf KB, Figg WD: The control of prostate-specific antigen expression and gene regulation by pharmacological agents. Pharmacol Rev 53:73,2001-91,","DOI":"10.1016\/S0031-6997(24)01480-7"},{"key":"R30","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.5.9.3287"},{"key":"R31","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)37426-8"},{"key":"R32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.01.529"},{"key":"R33","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.10.045"},{"key":"R34","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.146.2.6294738"},{"key":"R35","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.1990.66.s5.1009"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0909"},{"key":"R37","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21799"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2007.12.4487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T15:47:16Z","timestamp":1738079236000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2007.12.4487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,1]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,3,1]]}},"alternative-id":["10.1200\/JCO.2007.12.4487"],"URL":"https:\/\/doi.org\/10.1200\/jco.2007.12.4487","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3,1]]}}}